Evidence map›Paper›PMID 31650645›Full record

ReviewTransplant international : official journal of the European Society for Organ Transplantation2020

Novel insights into non-HLA alloimmunity in kidney transplantation.

Roman Reindl-Schwaighofer, Andreas Heinzel, Guido A Gualdoni, Laurent Mesnard, Frans H J Claas, Rainer Oberbauer

Open access · hybridAbstract readReview
In one paragraph

Review in Transplant international : official journal of the European Society for Organ Transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Genome-wide donor-recipient non-HLA mismatch and graft loss.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Development of Non-HLA Antibodies and Their Association With Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Autoantibodies against DNA topoisomerase I promote renal allograft rejection by increasing alloreactive T cell responses.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Roman Reindl-SchwaighoferDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4419-6282
Andreas HeinzelDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-8447-1795
Guido A GualdoniDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Laurent MesnardSorbonne Université, Urgences Néphrologiques et Transplantation Rénale, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Tenon, Paris, France.
Frans H J ClaasDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
Rainer OberbauerDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-7544-6275
Medical University of Vienna · ATLeiden University Medical Center · NLSorbonne Université · FR

Funding

Oesterreichische Nationalbank 17289Vienna Science and Technology Fund LS16-019Vienna Science and Technology Fund LS18-031
6 · The paper itself

Abstract

Recognition of non-self structures on donor cells represents the main immunological barrier in solid organ transplantation. The human leukocyte antigens (HLA) are considered the most important non-self (allo)antigens in transplantation. Long-term graft attrition is mainly caused by the formation of alloreactive antibodies that are directed against non-self structures (i.e., epitopes) on cell surface proteins. Recently published data provided evidence for a similar importance of non-HLA mismatches between donors and recipients in acute rejection as well as long-term kidney allograft survival. These data suggest a broader concept of immunological non-self that goes beyond HLA incompatibility and expands the current concept of polymorphic non-self epitopes on cell surface molecules from HLA to non-HLA targets. Amino acid substitutions caused by single nucleotide variants in protein-coding genes or complete loss of gene expression represent the basis for polymorphic residues in both HLA and non-HLA molecules. To better understand these novel insights in non-HLA alloimmunity, we will first review basic principles of the alloimmune response with a focus on the HLA epitope concept in donor-specific antibody formation before discussing key publications on non-HLA antibodies.

Indexed as

Graft SurvivalHistocompatibilityKidney TransplantationEpitopesGraft RejectionHLA AntigensHumansMembrane ProteinsEpitopesHLA AntigensMembrane Proteinsdonor-specific antibodiesepitopesgenome-wide incompatibilitynon-HLA Alloimmunity

Identifiers

PMID31650645
PMCPMC6972536
OpenAlexW2981844080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.